SNSE logo

Sensei Biotherapeutics, Inc. (SNSE)

Profile

Full Name

Sensei Biotherapeutics, Inc.

Ticker

NASDAQ: SNSE

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 4, 2021

Indexes

Not included

Website

https://www.senseibio.com

Employees

14

Key Details

Price

$11.70(-33.43%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-$24.01(-1868.28% YoY)

PE Ratio

-

Next earnings date

Nov 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $11.70
    SNSE price is $11.70

    30-Day Relative Volume

    20.02
    SNSE 30-day relative volume is 20.02

    Price Performance

    Price Most Recent Change

    -33.43%
    SNSE price was down -33.43% on Oct 17, 2025

    Price YTD Change

    +19.39%
    SNSE price is up +19.39% since January 1st

    Price 1-Year Change

    +37.97%
    SNSE price is up +37.97% year-on-year

    Price 3-Year Change

    -59.93%
    SNSE price is down -59.93% over the past 3 years

    Price Range

    Price All-Time High

    $530.00
    SNSE price is currently -97.79% below its historical high of $530.00

    Price 3-Year Low

    $5.00
    SNSE price is currently +134.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $14.75M
    SNSE market cap is $14.75 million

    Market Cap 3-Year Change

    -67.12%
    SNSE market cap is down -67.12% over the past 3 years

    Market Cap All-Time High

    $672.44M
    SNSE market cap is currently -97.81% below its historical high of $672.44 million

    Market Cap Sector Percentile

    19.06%
    SNSE market cap is higher than 19.06% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.22%
    SNSE shares outstanding is up +0.22% year-on-year

    Shares Outstanding 3-Year Change

    -17.94%
    SNSE shares outstanding is down -17.94% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.79
    SNSE beta is 0.79

    200-day SMA

    $8.54
    SNSE price is currently +37.01% above its 200-day simple moving average

    50-day SMA

    $9.27
    SNSE price is currently +26.16% above its 50-day simple moving average

    14-Day RSI

    53.22
    SNSE 14-day relative strength index is 53.22

    Volume

    20.02
    SNSE 30-day relative volume is 20.02

    ATR

    $1.53
    SNSE average true range is $1.53

    10-day Historical Volatility

    254.41%
    SNSE 10-day historical volatility is 254.41%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    SNSE annual revenue is $0.00

    Revenue Analysts Estimate

    -
    SNSE annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    0%
    SNSE annual revenue has remained unchanged year-on-year

    Revenue Sector Percentile

    28.76%
    SNSE annual revenue is higher than 28.76% of companies in Healthcare sector

    EPS

    EPS

    -$24.01
    SNSE annual earnings per share is -$24.01

    EPS Analysts Estimate

    -$15.71
    SNSE annual earnings per share is currently -52.85% lower than the consensus analysts' forecast

    EPS 1-Year Change

    -1868.28%
    SNSE annual earnings per share is down -1868.28% year-on-year

    EPS Sector Percentile

    7.26%
    SNSE annual earnings per share is higher than 7.26% of companies in Healthcare sector

    Profit

    Gross Profit

    -$551.00K
    SNSE annual gross profit is -$551.00 thousand

    Gross Margin

    -
    SNSE annual gross profit margin value is unknown

    Operating Profit

    -$31.66M
    SNSE annual operating income is -$31.66 million

    Operating Margin

    -
    SNSE annual operating profit margin value is unknown

    Net Income

    -$30.16M
    SNSE annual net profit is -$30.16 million

    Net Margin

    -
    SNSE annual net profit margin value is unknown

    Expenses

    Total Expenses

    $31.66M
    SNSE annual total expenses is $31.66 million

    Operating Expenses

    $31.66M
    SNSE annual total operating expenses is $31.66 million

    Cost Of Goods Sold

    $551.00K
    SNSE annual cost of goods sold is $551.00 thousand

    Selling, General & Administrative Expenses

    $13.04M
    SNSE annual SG&A is $13.04 million

    Depreciation & Amortization

    $1.32M
    SNSE annual D&A is $1.32 million

    Interest Expense

    $90.00K
    SNSE annual interest expense is $90.00 thousand

    Income Tax

    $0.00
    SNSE annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$30.07M
    SNSE annual earnings before interest & taxes is -$30.07 million

    EBITDA

    -$28.75M
    SNSE annual EBITDA is -$28.75 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $46.21M
    SNSE annual total assets is $46.21 million

    Non Current Assets

    $3.43M
    SNSE annual long term assets is $3.43 million

    Current Assets

    $41.93M
    SNSE annual total current assets is $41.93 million

    Cash and Cash Equivalents

    $9.99M
    SNSE annual cash & cash equivalents is $9.99 million

    Accounts Receivable

    -
    SNSE annual accounts receivable value is unknown

    Inventory

    $0.00
    SNSE annual inventory is $0.00

    Liabilities

    Total Liabilities

    $7.82M
    SNSE annual total liabilities is $7.82 million

    Long Term Liabilities

    $1.53M
    SNSE annual total long term liabilities is $1.53 million

    Current Liabilities

    $5.45M
    SNSE annual current liabilities is $5.45 million

    Accounts Payable

    $1.25M
    SNSE annual accounts payable is $1.25 million

    Debt

    Total Debt

    $3.85M
    SNSE annual total debt is $3.85 million

    Total Debt 1-Year Change

    -38.06%
    SNSE annual total debt is down -38.06% year-on-year

    Long Term Debt

    $1.53M
    SNSE annual long term debt is $1.53 million

    Short Term Debt

    $2.32M
    SNSE annual short term debt is $2.32 million

    Equity & Capital

    Shareholders Equity

    $38.39M
    SNSE annual stockholders equity is $38.39 million

    Book Value

    $38.39M
    SNSE annual book value is $38.39 million

    Retained Earnings

    -$262.05M
    SNSE annual retained earnings is -$262.05 million

    Working Capital

    $36.48M
    SNSE annual working capital is $36.48 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$24.67M
    SNSE annual cash from operations is -$24.67 million

    Cash From Operations 1-Year Change

    +22.96%
    SNSE annual cash from operations is up +22.96% year-on-year

    Cash From Investing

    $22.44M
    SNSE annual cash from investing is $22.44 million

    Cash From Investing 1-Year Change

    -41.58%
    SNSE annual cash from investing is down -41.58% year-on-year

    Cash From Financing

    -$787.00K
    SNSE annual cash from financing is -$787.00 thousand

    Cash From Financing 1-Year Change

    +92.96%
    SNSE annual cash from financing is up +92.96% year-on-year

    CAPEX

    CAPEX

    $146.00K
    SNSE annual capital expenditures is $146.00 thousand

    CAPEX 1-Year Change

    -18.89%
    SNSE annual capital expenditures is down -18.89% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$24.82M
    SNSE annual free cash flow is -$24.82 million

    Free Cash Flow 1-Year Change

    +22.94%
    SNSE annual free cash flow is up +22.94% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    SNSE annual gross profit margin value is unknown

    Operating Margin

    -
    SNSE annual operating profit margin value is unknown

    Net Margin

    -
    SNSE annual net profit margin value is unknown

    ROA & ROE

    ROA

    -50.02%
    SNSE annual return on assets is -50.02%

    ROE

    -58.40%
    SNSE annual return on equity is -58.40%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    SNSE price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    SNSE price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    0.54
    SNSE price to book ratio is 0.54

    PB Ratio Sector Percentile

    24.89%
    SNSE price to book ratio is higher than 24.89% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    SNSE price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    SNSE price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    -$11.32M
    SNSE enterprise value is -$11.32 million

    Enterprise Value Sector Percentile

    3.67%
    SNSE enterprise value is higher than 3.67% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    0.42
    SNSE EV/EBITDA is 0.42

    EV/EBITDA Sector Percentile

    71.21%
    SNSE EV/EBITDA is higher than 71.21% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    7.70
    SNSE annual current ratio is 7.70

    Quick Ratio

    7.70
    SNSE annual quick ratio is 7.70

    Leverage

    Debt To Equity

    0.10
    SNSE annual debt to equity ratio is 0.10

    Interest Coverage Ratio

    -334.08
    SNSE annual interest coverage ratio is -334.08

    Risk & Stability

    F-Score

    -
    SNSE piotroski f-score value is unknown

    Altman Z-Score

    -8.01
    SNSE altman z-score is -8.01

    Analyst ratings

    Recent major analysts updates

    Aug 5, 25 HC Wainwright & Co.
    Buy
    Mar 28, 25 Oppenheimer
    Outperform
    Mar 28, 25 HC Wainwright & Co.
    Buy
    Jan 10, 25 HC Wainwright & Co.
    Buy
    Jan 8, 25 HC Wainwright & Co.
    Buy
    Aug 7, 24 HC Wainwright & Co.
    Buy
    May 24, 24 Stephens & Co.
    Overweight
    May 24, 24 HC Wainwright & Co.
    Buy
    May 14, 24 Stephens & Co.
    Overweight
    Dec 4, 23 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with SNSE included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Sensei Biotherapeutics, Inc.?
    • Does Sensei Biotherapeutics, Inc. pay dividends?
    • What sector is Sensei Biotherapeutics, Inc. in?
    • What industry is Sensei Biotherapeutics, Inc. in?
    • What country is Sensei Biotherapeutics, Inc. based in?
    • When did Sensei Biotherapeutics, Inc. go public?
    • Is Sensei Biotherapeutics, Inc. in the S&P 500?
    • Is Sensei Biotherapeutics, Inc. in the NASDAQ 100?
    • Is Sensei Biotherapeutics, Inc. in the Dow Jones?
    • When was Sensei Biotherapeutics, Inc.'s last earnings report?
    • When does Sensei Biotherapeutics, Inc. report earnings?

    What is the ticker symbol for Sensei Biotherapeutics, Inc.?

    The ticker symbol for Sensei Biotherapeutics, Inc. is NASDAQ:SNSE

    Does Sensei Biotherapeutics, Inc. pay dividends?

    No, Sensei Biotherapeutics, Inc. does not pay dividends

    What sector is Sensei Biotherapeutics, Inc. in?

    Sensei Biotherapeutics, Inc. is in the Healthcare sector

    What industry is Sensei Biotherapeutics, Inc. in?

    Sensei Biotherapeutics, Inc. is in the Biotechnology industry

    What country is Sensei Biotherapeutics, Inc. based in?

    Sensei Biotherapeutics, Inc. is headquartered in United States

    When did Sensei Biotherapeutics, Inc. go public?

    Sensei Biotherapeutics, Inc.'s initial public offering (IPO) was on February 4, 2021

    Is Sensei Biotherapeutics, Inc. in the S&P 500?

    No, Sensei Biotherapeutics, Inc. is not included in the S&P 500 index

    Is Sensei Biotherapeutics, Inc. in the NASDAQ 100?

    No, Sensei Biotherapeutics, Inc. is not included in the NASDAQ 100 index

    Is Sensei Biotherapeutics, Inc. in the Dow Jones?

    No, Sensei Biotherapeutics, Inc. is not included in the Dow Jones index

    When was Sensei Biotherapeutics, Inc.'s last earnings report?

    Sensei Biotherapeutics, Inc.'s most recent earnings report was on August 5, 2025

    When does Sensei Biotherapeutics, Inc. report earnings?

    The next expected earnings date for Sensei Biotherapeutics, Inc. is November 14, 2025
    On this page